Technology | Left Atrial Appendage (LAA) Occluders | February 09, 2016

Medicare Will Cover Watchman Left Atrial Appendage Closure Device

CMS will now cover percutaneous LAA occlusion therapy for Medicare beneficiaries consistent with the FDA label when specific conditions are met

Watchman, left atrial appendage closure, LAA occluder
Watchman, left atrial appendage closure, LAA occluder

February 9, 2016 — Boston Scientific Corp. announced the Centers for Medicare and Medicaid Services (CMS) will cover percutaneous left atrial appendage (LAA) closure therapy under specific criteria, as outlined in the agency's final National Coverage Determination (NCD). This decision, effective immediately, provides consistent and uniform access to the Watchman LAA closure Device as a non-pharmacological treatment option for stroke risk reduction for appropriate Medicare beneficiaries. 

The Watchman device, the first and only percutaneous LAA occluder approved by the U.S. Food and Drug Administration (FDA) in March 2015, is indicated for patients with non-valvular atrial fibrillation (AF) who are at high stroke risk, suitable for warfarin, and are seeking an alternative to long-term warfarin therapy.   

According to the NCD, CMS will cover percutaneous LAAC therapy when specific conditions are met. CMS adopted the majority of physician and professional medical society feedback received in the 30-day public comment period, specifically as it relates to patient coverage criteria and future data collection requirements. 

Medicare beneficiaries account for the overwhelming majority of patients deemed candidates for the Watchman. The remaining population is represented by private payers. Prior to the CMS final decision, a number of private payers, including several Blue Cross Blue Shield plans, have updated their policies to now cover the Watchman device.

The Watchman is a catheter-delivered heart implant designed to close the LAA in order to prevent the migration of blood clots from the LAA, and thus, reduce the incidence of stroke and systemic embolism for higher risk patients with non-valvular AF. The LAA is a thin, sack-like appendix arising from the heart and is believed to be the source of >90 percent of stroke-causing clots that come from the left atrium in patients with non-valvular AF. 

For more information: www.bostonscientific.com


Related Content

News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
News | Cardiovascular Business

June 28, 2024 — After a year of dedicated service and outstanding leadership, Jodie L. Hurwitz, MD, FHRS, has now ended ...

Home June 28, 2024
Home
News | Cardiovascular Business

June 26, 2024 — The first issue of JACC, the flagship journal of the American College of Cardiology, under new Editor-in ...

Home June 26, 2024
Home
News | Cardiovascular Business

June 24, 2024 — Aakriti Gupta, MD, and Michelle Kittleson, MD, PhD, cardiologists in the Smidt Heart Institute at Cedars ...

Home June 24, 2024
Home
Feature | Cardiovascular Business

June 24, 2024 — Well-known Chicago and worldwide philanthropist Ann Lurie, namesake of the Ann and Robert H Lurie ...

Home June 24, 2024
Home
Subscribe Now